Johnson & Johnson (JNJ)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Johnson & Johnson (JNJ)
Go deeper and ask any question about JNJ
Company Performance
Current Price
as of Oct 04, 2024$160.29
P/E Ratio
23.17
Market Cap
$385.86B
Description
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Metrics
Overview
- HQNew Brunswick, NJ
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerJNJ
- Price$160.29-0.13%
Trading Information
- Market Cap$385.86B
- Float99.85%
- Average Daily Volume (1m)5,753,011
- Average Daily Volume (3m)6,606,722
- EPS$6.98
Company
- Revenue$86.57B
- Rev Growth (1yr)-12.12%
- Net Income$4.69B
- Gross Margin68.99%
- EBITDA Margin36.26%
- EBITDA$8.14B
- EV$370.02B
- EV/Revenue4.27
- P/E23.17
- P/S4.48